XML 44 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of federal and state statutory tax rates and the provision for income tax benefit
   2020   2019 
Federal  $-   $- 
Foreign   -    - 
State   (836,893)   (610,676)
Income tax benefit  $(836,893)  $(610,676)
Schedule of deferred tax assets and liabilities
   2020   2019 
Net operating loss carry forwards  $27,022,000   $23,936,000 
Orphan drug and research and development credit carry forwards   8,149,000    8,315,000 
Equity based compensation   264,000    1,331,000 
Intangibles   817,000    1,051,000 
Total   36,252,000    34,633,000 
Valuation allowance   (36,252,000)   (34,633,000)
Net deferred tax assets  $-   $- 
Schedule of federal and state statutory tax rates and the provision for income tax benefit
   2020   2019 
Federal tax at statutory rate   (21.0)%   (21.0)%
State tax benefits, plus sale of NJ NOL, net of federal benefit   (5.8)   (8.8)
Foreign tax rate difference   0.1    0.3 
Orphan drug and research and development credits   4.8    1.8 
Permanent differences   1.4    2.1 
Foreign NOL adjustments   0.4    2.5 
Expiration of tax attributes   6.9    8.8 
Change in valuation allowance   8.7    8.3 
Income tax benefit   (4.5)%   (6.0%)